Blog
How to Successfully Conduct Virtual Investigator Meetings
Explore best practices to conduct virtual investigator meetings to increase comprehension and expedite site activation.
Cell & Gene Therapy vs Drug Research: What’s the Difference?
In the past year, cell and gene therapy research has exploded. Understand how this field differs from traditional drug development.
Addressing Barriers to DEI in Clinical Research
A diverse, equitable, & inclusive research environment benefits everyone: trials & the communities alike. How can sites incorporate more DEI?
Making the Most of Site Training: Lessons from the Pandemic
Ensure that your next remote site initiation visit is both productive and useful despite the virtual setting with these tips
The Power Of Patient Advocacy In Drug Development
This blog outlines the origins and rise of patient advocacy groups, discussing the milestones in the FDA's acceptance of these groups.
Q&A from Remote Monitoring: Study Compliance In A Changing World
In a recent webinar, Advarra experts provided insights and information in Remote Monitoring: Study Compliance in a Changing World
Pitfalls of Chemistry, Manufacturing, and Controls in Investigational New Drug Preparation
Submitting an Investigational New Drug (IND) application for the first time? Consider three common CMC pitfalls that may impact submission.
Regulatory Fine Points: What Research Sites Need to Do for Part 11 Compliance
Summary of James Riddle's Presentation at SQA, which outlines considerations for sponsors when ensuring 21 CFR Part 11 compliance at sites.
How to Be Research Ready: Today and Beyond
If presented with a new study, are you prepared to take it on? Efficient study activation can set the pace for a successful clinical trial.
Building a Foundation for Regulatory Success in the Post-Pandemic Landscape
Read how an eRegulatory system can increase productivity, improve compliance, and ensure a return on your technology investment.
Q&A: FDA Inspections of Clinical Investigators: Understanding the Process and What to Expect
Q&A from our 4/21 webinar outlining what to expect in an FDA inspection and how to have a more positive experience.
Phase I Oncology Clinical Trials
This blog discusses what makes Phase I oncology trials complex and what IRBs need to know as they review a Phase I trial.
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2024 Advarra. All Rights Reserved.